Official recall notice

FDA DrugClass IINotable

Vancomycin Injection Recall (Sep 2026) – Baxter Healthcare

Product: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.

Recall date
2026-09-09
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

CGMP Deviations

Affected products

Lot # NC193894, Exp Date: 04/25/2027.

Verify with the official notice →
Share:

Related Recalls

2026-09-30 · FDA_DEVICE
FDA Recall: PRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system
Baxter Healthcare Corporation
2026-09-30 · FDA_DEVICE
FDA Recall: PRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a non-powe
Baxter Healthcare Corporation
2026-09-30 · FDA_DEVICE
FDA Recall: PRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system
Baxter Healthcare Corporation
2026-09-30 · FDA_DEVICE
FDA Recall: Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Model/Catalog Number: M08594A Software V
Baxter Healthcare Corporation